Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating and $15.00 ...

Retrieved on: 2019-04-04 20:11:15

Tags for this article:

Finance

NASDAQ

Economy of the United States

Financial markets

Economy of New York City

Arcturus Therapeutics Ltd.

Click the tags to see associated articles and topics

Arcturus Therapeutics Ltd (NASDAQ:ARCT) has coverage initiated with a Buy rating and $15.00 .... View article details on hiswai:

Excerpt

<div>... Ultragenyx Pharmaceutical, Inc., Takeda Pharmaceutical Company Limited, <b>Synthetic Genomics</b> Inc., CureVac AG, and Cystic Fibrosis Foundation ...</div>

Article found on:

View Original Article